Home > Boards > Free Zone > Big Board Trading - Technical > Naz News, Gappers and FLE''s

CNBCU.S. stock futures were starting April higher after

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
MiamiGent Member Profile
Member Level 
Followed By 240
Posts 36,622
Boards Moderated 6
Alias Born 08/16/08
160x600 placeholder
Corn Futures Falls as Rainfall is Expected -- Daily Grain Highlights
By Paulo Trevisani
Top Company News of the Day
Front Month Nymex Natural Gas Rose 10.51% This Week to Settle at $4.0600 -- Data Talk
Front Month Nymex RBOB Gasoline Rose 1.67% This Week to Settle at $2.2913 -- Data Talk
Grimmway Farms Recalls Certain Carrots Due to Risk of Salmonella
Kimberly-Clark Reports 2Q Results, Offers Guidance -- Commodity Comment
GDP Growth Expected to Accelerate in 2Q -- Data Week Ahead
Veoneer Shares Touch 52-week High, Magna Plans to Acquire Co.
AbbVie Gets FDA OK for Pediatric Skin Infection Drug
FTSE 100 Index Ends the Week 0.28% Higher at 7027.58 -- Data Talk
STOXX Europe 50 Index Ends the Week 0.84% Higher at 3558.08 -- Data Talk
CAC 40 Index Ends the Week 1.68% Higher at 6568.82 -- Data Talk
DAX Ends the Week 0.83% Higher at 15669.29 -- Data Talk
STOXX Europe 600 Index Ends the Week 1.49% Higher at 461.51 -- Data Talk
EURO STOXX 50 Index Ends the Week 1.82% Higher at 4109.10 -- Data Talk
FTSE 100 Closed Higher Despite Volatile Week
Vonovia Unlikely to Secure Enough Support From Deutsche Wohnen Shareholders to Pursue Takeover
Kimberly-Clark Keeps Forecast of Favorable FX in 2021 -- Currency Comment
U.S. Economic Growth Moderated in July -- IHS Markit
Veoneer Shares Climb on Magna Acquisition Deal
FTSE Rises, Covid-19 Strategy and Brexit Tensions Could Hit Pound
AstraZeneca's Bydureon BCise Gets U.S. Approval For Type 2 Diabetes in Pediatric Patients
NextEra Energy 2Q Profit Declines on Lower Revenue
Kimberly-Clark Cuts Full-Year Guidance Due to Inflation
Kimberly-Clark 2Q Hit by Higher Input Costs, Reversal in Demand
MiamiGent Member Level  Thursday, 04/01/21 09:42:51 AM
Re: None
Post # of 376063 

U.S. stock futures were starting April higher after the S&P 500 closed out its best month since November with a gain of 4.2%. The index hit an all-time intraday high Wednesday but failed to close at a record. (CNBC)

The Dow, which closed at a record Monday, saw its second modest decline in a row Wednesday. But the 30-stock average, like the S&P 500, had its best month since November, posting a March gain of 6.6%. For the first quarter, the Dow and the S&P 500 rose 7.8% and 5.8%, respectively, for their fourth positive quarter in a row. (CNBC)

The Nasdaq broke a two-session losing streak with a 1.5% gain Wednesday. The tech-heavy Nasdaq has recently been the underperformer as technology stocks are especially sensitive to rising market interest rates because they depend on borrowing money cheaply to invest in future growth. For March, the Nasdaq gained just 0.4%. For the quarter, it gained 2.8%. (CNBC)

The government this morning reported a higher-than-expected 719,000 new filings for unemployment benefits last week. The prior week was revised lower to 658,000 initial jobless claims, the lowest level in over a year. The Labor Department is set to issue its monthly employment report Friday despite the Good Friday closure of the stock market.

* 10-year Treasury yield dips below 1.7% after of jobless claims data (CNBC)
* Oil gains ground ahead of OPEC+ meeting on output policy (Reuters)


Pfizer (PFE) and BioNTech (BNTX) said Thursday their two-shot Covid vaccine is around 91% effective, citing updated trial data, which included people inoculated for up to six months. The vaccine was also 100% effective, among trial participants in South Africa, where a new variant is dominant. However, the number of those South Africa participants was relatively small at 800. (Reuters)

Shares of Emergent BioSolutions (EBS) , the company at the center of problems that led Johnson & Johnson (JNJ) to discard an unknown amount of its Covid vaccine, dropped 7% in Thursday's premarket. According to records obtained by The Associated Press through the Freedom of Information Act, Emergent has had a string of citations from U.S. health officials for quality control problems.

The FDA cleared Abbott Laboratories' (ABT) Covid-19 rapid antigen test for over-the-counter sales and use at home for people without current Covid symptoms. The retail price is still undetermined, but a company spokeswoman told Reuters the tests will be sold to retailers for less than $10 each. At the same time, the FDA also approved an at-home test for Covid-19 made by diagnostics company Quidel (QDEL).

Employees at Alphabet's (GOOGL) Google will begin returning to offices in a "limited" capacity in April, according to internal documents viewed by CNBC. After Sept. 1, if employees want to work remotely for more than 14 days per year, they will need to formally apply. Google advised employees to get a Covid vaccine but said it's not mandatory.

* Frontier Airlines raises $570 million in IPO, starts trading today (CNBC)

* SoftBank-backed Compass raises $450 million in downsized IPO (Reuters)
Microsoft (MSFT) will deliver to the U.S. Army over 120,000 devices based on its HoloLens augmented reality headset. The deal, which could be worth as much as nearly $22 billion over 10 years, comes a year and a half after Microsoft won a cloud contract from the Pentagon that could be worth up to $10 billion. (CNBC)

* Elon Musk tapped to join board of Endeavor Group, owner of UFC and Miss Universe contest (CNBC)


Shares of Funko (FNKO) surged in premarket trading Thursday after the pop culture collectible maker said it acquired a majority stake in TokenWave, putting it into the NFT, nonfungible token, market.

Exxon Mobil (XOM) released data in a SEC filing that points to the possibility of the company's first profit in five quarters. Raymond James analyst Justin Jenkins said the data points to a profit of $2.55 billion, or 60 cents per share, with Exxon benefiting from higher oil and gas prices.

Auto retailer CarMax (KMX) quarterly earnings of $1.27 per share, with revenue essentially in line with forecasts. CarMax also announced it would acquire the remaining part of Edmunds that it didn't already own, in a cash-and-stock deal valuing the auto information provider at $404 million. CarMax shares slid 3.5% in the premarket.

Micron Technology (MU) reported quarterly profit of 98 cents per share, beating estimates. Revenue was slightly above Wall Street forecasts. The computer chip maker also issued an upbeat forecast. Separately, The Wall Street Journal reported Micron is exploring a deal for Kioxia that could value the Japanese chip maker at around $30 billion. Micron shares jumped 4.5% in the premarket.

Taiwan Semiconductor (TSM) will invest $100 billion over the next three years to increase manufacturing capacity at its plants, in a move to deal with increased demand and a worldwide shortage of chips. Taiwan Semi rose 2.1% in the premarket.

China-based electric vehicle maker Nio (NIO) said it delivered 7,257 vehicles in March, a 373% increase over the same month last year. Nio surged 5.8% in premarket trading.

Sherwin-Williams' (SHW) 3-for-1 stock split, announced on March 2, is effective as of today. It's the first time the paint company has split its stock since 1997. Sherwin-Williams gained 1.2% in the premarket.

FuboTV (FUBO), a live streaming sports TV platform, announced an agreement to carry all non-nationally televised Chicago Cubs games this season. FuboTV shares jumped 4.8% in the premarket.


Matthew J. Belvedere

Peter Schacknow

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences